Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

What Does Glutathione Reductase Do?

A stylized dimeric enzyme converts paired oxidized glutathione into separate reduced glutathione molecules.

Glutathione reductase (GR; EC 1.8.1.7) recycles oxidized glutathione. Using NADPH as the electron donor, it reduces one molecule of glutathione disulfide (GSSG) to two molecules of reduced glutathione (GSH). It is a flavoprotein homodimer belonging to the glutathione-disulfide oxidoreductase family; its FAD cofactor connects NADPH to a redox-active disulfide in the enzyme.[1]

This regeneration helps maintain the reducing capacity of the glutathione pool. GR does not replace glutathione peroxidase: the peroxidase uses GSH while reducing peroxides, whereas GR restores GSH from the resulting GSSG. The enzymes perform complementary reactions in the glutathione redox cycle.[1]

What reaction does glutathione reductase catalyze?

The central conversion is one GSSG to two GSH, coupled to oxidation of NADPH to NADP⁺. GSSG contains a disulfide linking two glutathione units; reduction restores their sulfhydryl forms. GR therefore regenerates existing glutathione rather than synthesizing new glutathione molecules. In humans, the enzyme is encoded by the *GSR* gene.[1]

The distinction between recycling and synthesis matters when interpreting glutathione measurements. A change in the GSH/GSSG ratio describes the balance between reduced and oxidized forms, not simply the amount of glutathione present. NADPH-dependent regeneration by GR helps sustain the high intracellular GSH/GSSG ratio associated with a reducing cellular environment.[1]

How electrons move from NADPH to GSSG

A conceptual enzyme cutaway shows an electron donor and a catalytic disulfide on opposite sides of a flavin cofactor.

The electron-transfer sequence is NADPH → FAD → the enzyme’s redox-active disulfide → GSSG. FAD is an intermediate electron carrier, not the glutathione substrate. The active-site cysteine pair cycles between disulfide and reduced forms as the enzyme accepts reducing equivalents and transfers them to GSSG.[1]

Catalysis can be described as two linked half-reactions:

  1. Reduction of the enzyme. NADPH supplies reducing equivalents to bound FAD, which transfers them to the redox-active disulfide.
  2. Reduction of the substrate. The reduced active site reacts with GSSG through thiol–disulfide exchange. A transient enzyme–glutathione mixed disulfide is resolved, proton transfer accompanies GSH release, and the enzyme’s disulfide is restored.[1]

Human GR crystal structures at nominal resolutions of 0.95–1.1 Å place NADPH and the redox-active disulfide on opposite sides of the flavin. Their geometry supports the flavin’s role in connecting the electron donor to the catalytic disulfide. Active-site compression also distorts the nicotinamide ring of bound NADPH, which the structural study links to enhanced catalysis through stereoelectronic effects.[2]

These structural details explain more than a simple binding diagram: catalysis depends on how the protein positions its substrates and cofactor. However, not every unusual structural feature drives the reaction. The same study found distortion in the disulfide loop in both oxidized and reduced structures, rather than a strain that appeared only during one catalytic state.[2]

Structure: a homodimer with cofactor-binding domains

Human erythrocyte GR has a homodimeric architecture, with domains involved in NADPH binding, FAD binding and dimerization. The dimerization domain provides the structural interface between the subunits, while the cofactor-binding regions organize the electron-transfer machinery.[1]

The active site is therefore not simply a pocket that holds GSSG. It must accommodate the electron donor, retain the flavin and position the catalytic disulfide for successive reduction and oxidation. The human substrate-complex structures directly demonstrate the close spatial organization of NADPH, flavin and the disulfide.[2]

NADPH supply and glutathione compartments

A cell schematic shows glutathione moving from the cytosol into a distinct mitochondrial pool.

GR activity depends on access to NADPH as well as functional enzyme. Glucose-6-phosphate dehydrogenase, part of the oxidative pentose phosphate pathway, is generally considered the main source of cytoplasmic NADPH. Other cytosolic and mitochondrial enzymes also contribute to NADPH production.[3] Consequently, an enzyme-capacity measurement alone cannot describe the supply of reducing equivalents available inside a cell.

Glutathione itself is compartmentalized. It is synthesized in the cytosol and transported into mitochondria, where it forms a distinct pool regulated separately from the cytosolic pool. Mitochondria cannot synthesize glutathione de novo.[4] A whole-cell measurement therefore cannot identify which compartment accounts for a change in glutathione balance.

GR-dependent NADPH consumption has been measured in both the cytosol and mitochondria of RAW264.7 macrophages using compartment-targeted sensors. In that cell model, oxidized-low-density-lipoprotein loading followed by inflammatory stimulation increased GSR expression and correlated with faster NADPH consumption. The method requires transfectable cells, and the authors identify high expression of the introduced sensors relative to endogenous glucose-6-phosphate dehydrogenase as a limitation.[5]

These cellular measurements answer a different question from purification of GR from a tissue. Purified enzyme reveals catalytic properties; targeted sensors reveal compartment-associated consumption in the particular cells studied. Neither result alone establishes enzyme abundance across all tissues.

Substrates and kinetic measurements

GR couples two defined substrates: NADPH supplies reducing equivalents, and GSSG accepts them. Kinetic measurements examine how turnover depends on their concentrations rather than treating enzyme activity as a fixed property independent of assay conditions.

For purified bovine kidney cortex GR, reported Km values were 18 ± 3 µM for NADPH and 65 ± 5 µM for GSSG. Product-inhibition experiments supported a branched kinetic mechanism.[6] These values belong to that purified bovine preparation under the study’s conditions; they are not universal constants or measurements of human cellular substrate availability.

The structural and kinetic descriptions are complementary. Structures show how reaction partners are positioned, while substrate and product measurements describe the behavior of the enzyme preparation during turnover. A kinetic constant should therefore retain its species, tissue and experimental context.

Regulation: Nrf2 and riboflavin

*GSR* participates in the Keap1/Nrf2/antioxidant-response-element transcriptional program. Under basal conditions, interaction with Keap1 promotes continuous Nrf2 ubiquitination and degradation. Oxidative or electrophilic stress modifies critical Keap1 cysteines, allowing Nrf2 stabilization and nuclear translocation. Nrf2 then activates genes including *GSR*, the glutathione-synthesis genes *GCLC* and *GCLM*, and genes for glutathione peroxidases and glutathione S-transferases.[4]

This coordinated response links glutathione regeneration with synthesis and other protective pathways. Increased GR expression can accompany a stress response; it should not automatically be interpreted as evidence that oxidative stress is absent.

Cofactor availability is a separate influence. Riboflavin is a precursor of FAD, and riboflavin deficiency has been associated with moderate GR deficiency in some populations.[3] Thus, enzyme abundance and measured catalytic activity are related but are not interchangeable measurements.

What happens when glutathione reductase is inhibited or deficient

Human observations. Rare homozygous pathogenic *GSR* variants have been reported with hemolytic anemia and cataract, or hyperbilirubinemia and jaundice. Tested cells from patients in two families had very low or absent GR activity. The available reports did not comprehensively exclude other genetic explanations through whole-exome analysis.[3] These are case-level observations, not evidence for a treatment or a diagnostic threshold applicable to the general population.

Animal models. A review reports a healthy phenotype in *Gsr*-knockout mice.[3] This contrasts with the reported human cases and cautions against assuming that loss of the same enzyme produces identical outcomes across species.

Experimental inhibition. BCNU, also called carmustine, is a concentration- and time-dependent irreversible GR inhibitor. In vitro inactivation occurs after biochemical reduction of the enzyme in the presence of NADPH. In isolated rat ileum, BCNU reduced both GR activity and contraction amplitude.[7] This is an ex vivo tissue result: the measured association concerns an organ-bath preparation, not a demonstrated effect in people.

How glutathione reductase activity and the GSH/GSSG ratio are measured

GR can serve as both the subject of an assay and a reagent in an analytical assay. Those roles should not be confused. Measuring GR activity asks how rapidly an enzyme preparation catalyzes its reaction; using added GR to recycle glutathione helps measure the glutathione already present in a sample.

The Tietze enzymatic recycling approach uses GR-dependent reduction of GSSG to amplify the analytical signal through cycling. A methodological study adapted this approach to small blood volumes with spectrophotometer or microplate-reader detection.[8]

Sample handling is a major source of error. Artificial oxidation during preparation can increase measured GSSG and bias the GSH/GSSG ratio toward an apparently more oxidized state. A low ratio therefore requires attention to pre-analytical conditions before it is interpreted as a biological change.[8]

NADPH consumption provides another reaction-linked readout: one NADPH is oxidized for each GSSG reduced.[1] In cell experiments, attributing NADPH consumption to GR requires more than a whole-cell NADPH measurement. The RAW264.7 study used targeted sensors and experimental perturbations to resolve GR-dependent consumption in particular compartments.[5]

How GR connects with glutaredoxin and ER redox biology

The cytosol and mitochondrial matrix maintain reducing conditions through functionally overlapping thioredoxin and glutaredoxin systems. NADPH supplies the reducing equivalents that allow GR to maintain reduced glutathione and thioredoxin reductase to maintain reduced thioredoxins. GR therefore supports the reduced glutathione pool within this broader network rather than replacing either system.[9]

The endoplasmic reticulum and mitochondrial intermembrane space have a different task: they support oxidative protein folding and disulfide-bond formation. Reducing pathways remain important there for correcting disulfides, preparing proteins for degradation and balancing oxidation with reduction.[9] This functional connection does not establish that GR itself resides in the ER lumen. A compartment’s glutathione chemistry and the location of its recycling enzyme are distinct questions.

Related research: What Is Reduced Glutathione: GSH in Redox Research; Glutathione.

Research Use Only. This article is for laboratory research and analytical education, not a validated experimental protocol or medical or veterinary advice. It is not intended to guide administration to humans or animals.

References

  1. Glutathione reductase — encyclopedic background
  2. Berkholz et al., Catalytic cycle of human glutathione reductase near 1 Å resolution — abstract
  3. Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense
  4. Glutathione Biology in Neurodegenerative and Metabolic Diseases
  5. Ting et al., Measuring the rate of NADPH consumption by glutathione reductase in the cytosol and mitochondria
  6. Purification and kinetics of bovine kidney cortex glutathione reductase — abstract
  7. Grahovac et al., The Role of Cellular Glutathione Redox Cycle and Glutathione in the Regulation of Ileum Contractility
  8. Giustarini et al., An Artifact-Free Assay for the GSH/GSSG Ratio Adapted for Finger-Stick Blood Microvolumes
  9. Balancing oxidative protein folding: the influences of reducing pathways on disulfide bond formation — abstract